Meanwhile, as a prognostic biomarker, DLGAP5 was associated with poor prognosis in colorectal, endometrial, breast, and pancreatic cancers [15, 18, 20, 23]. The gene discussed is DLGAP5; the disease is pancreatic neoplasm.